NPR News: FDA approves Alzheimer's drug that appears to modestly slow disease

FDA approves Alzheimer's drug that appears to modestly slow disease
An Alzheimer's drug that removes the substance amyloid from the brain has received a conditional approval from the FDA. A large study found the drug decreased the loss of thinking and memory by 27%.

Read more on NPR